Clinical Trial

Epididymis Protein 4 and Pulmonary Function With Quality Improvement Protocol Among Cystic Fibrosis Patients

Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated April 8, 2025 (before its estimated October 7, 2025 completion). Its status may not reflect the trial's current state.
Summary
To implement a quality improvement plan aimed at achieving a 5% increase in the Forced expiratory volume in 1st second (FEV1) (% predicted value) in cystic fibrosis (CF) patients with impaired pulmonary function parameters over 12 months. Additionally, the plan aims to measure serum human epididymis protein 4 (HE4) levels in the studied subjects before and after pulmonary function improvement.
Trial Details
NCT Number NCT06915961
Lead Sponsor Ain Shams University
Conditions Cystic Fibrosis (CF)
Enrollment 35 participants
Start Date 2024-10-07
Primary Completion 2025-10-07 (estimated)
Study Completion 2025-12-12 (estimated)
Updated on ClinicalTrials.gov 2025-04-08